Authorizes pharmacists to dispense a one-time refill, for up to one hundred days under certain specified conditions.
Summary
S0483 would create a new authority for Rhode Island pharmacists to issue a one-time refill, for up to 100 days, when a patient needs continuation of therapy and the pharmacist cannot readily obtain refill authorization from the prescriber, or when the patient does not currently have a prescriber. The refill is limited to medications that are essential to sustaining life or treating a chronic condition, and the pharmacist must determine that interrupting therapy could reasonably cause undesirable health consequences or physical or mental discomfort.
The bill excludes Schedule II through V controlled substances and requires the dispensing pharmacist to notify the prescriber within seven business days. If no prescriber exists, the pharmacist must document that fact in the pharmacy’s internal records. The act takes effect July 1, 2025, and amends Rhode Island’s pharmacy laws in chapter 5-19.1 to add this new refill provision.
Impact
The bill expands pharmacists’ dispensing authority under Rhode Island law by creating a limited emergency/continuation-of-therapy refill option. It affects pharmacy practice, prescriber-pharmacist coordination, and patients who may otherwise experience gaps in treatment for chronic or life-sustaining medications. It does not alter controlled-substance rules for Schedule II-V drugs, and it adds notice and recordkeeping requirements to preserve accountability.
Sentiment
The available voting history shows strong, unanimous support at each recorded stage, with passage votes of 35-0 in the Senate and 67-0 in the House on amendment and final passage, followed by another 37-0 passage vote. No committee testimony is provided, but the recorded votes suggest broad bipartisan agreement and little visible opposition. The bill appears to have been viewed as a practical patient-access measure rather than a controversial policy change.
Contention
No formal opposition is reflected in the provided materials, and there are no committee transcripts indicating debate. The main policy boundaries built into the bill suggest the likely areas of concern: limiting the authority to non-controlled medications, capping the refill at 100 days, requiring pharmacist judgment about medical risk, and mandating prescriber notification or documentation when no prescriber exists. These safeguards appear designed to address concerns about scope of practice, patient safety, and continuity with the prescribing relationship.
Relating to the regulation of pharmacists and the practice of pharmacy, including the administration of a medication and the ordering and administration of an immunization or vaccination by a pharmacist.